IL75077A - N,3-disubstituted 2-oxindole-1-carboxamides and pharmaceutical compositions containing them - Google Patents
N,3-disubstituted 2-oxindole-1-carboxamides and pharmaceutical compositions containing themInfo
- Publication number
- IL75077A IL75077A IL75077A IL7507785A IL75077A IL 75077 A IL75077 A IL 75077A IL 75077 A IL75077 A IL 75077A IL 7507785 A IL7507785 A IL 7507785A IL 75077 A IL75077 A IL 75077A
- Authority
- IL
- Israel
- Prior art keywords
- oxindole
- carboxamides
- disubstituted
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- UYINJAQCJCYCGO-UHFFFAOYSA-N 2-oxo-3h-indole-1-carboxamide Chemical class C1=CC=C2N(C(=O)N)C(=O)CC2=C1 UYINJAQCJCYCGO-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 abstract 1
- JNYLMODTPLSLIF-UHFFFAOYSA-N 6-(trifluoromethyl)pyridine-3-carboxylic acid Chemical group OC(=O)C1=CC=C(C(F)(F)F)N=C1 JNYLMODTPLSLIF-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60735684A | 1984-05-04 | 1984-05-04 | |
| US06/714,012 US4569942A (en) | 1984-05-04 | 1985-03-22 | N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL75077A0 IL75077A0 (en) | 1985-09-29 |
| IL75077A true IL75077A (en) | 1988-03-31 |
Family
ID=27085497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL75077A IL75077A (en) | 1984-05-04 | 1985-05-02 | N,3-disubstituted 2-oxindole-1-carboxamides and pharmaceutical compositions containing them |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4569942A (fr) |
| EP (2) | EP0244918B1 (fr) |
| AT (2) | ATE53576T1 (fr) |
| AU (1) | AU554290B2 (fr) |
| CA (1) | CA1255658A (fr) |
| DE (2) | DE3571320D1 (fr) |
| DK (1) | DK162644C (fr) |
| GR (1) | GR851061B (fr) |
| IL (1) | IL75077A (fr) |
| NZ (1) | NZ211938A (fr) |
| PH (1) | PH22981A (fr) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE63543T1 (de) * | 1984-02-07 | 1991-06-15 | Pfizer | 2-oxindolzwischenprodukte. |
| US4730004A (en) * | 1986-01-22 | 1988-03-08 | Pfizer Inc. | Analgesic and anti-inflammatory 1-acyl-2-oxindole-3-carboxamides |
| US4791131A (en) * | 1985-07-09 | 1988-12-13 | Pfizer Inc. | Analgesic and antiinflammatory 1-acyl-2-oxindole-3-carboxamides |
| US4678802A (en) * | 1985-07-09 | 1987-07-07 | Pfizer Inc. | 1-acylcarbamoyloxindole-3-carboxamides as antiinflammatory agents |
| US5081131A (en) * | 1986-01-13 | 1992-01-14 | American Cyanamid Company | Omega-((hetero)alkyl)benz(cd)-indol-2-amines |
| DK288287A (da) * | 1986-06-09 | 1987-12-10 | Pfizer | Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande |
| GB8623819D0 (en) * | 1986-10-03 | 1986-11-05 | Glaxo Group Ltd | Heterocyclic compounds |
| WO1988005656A1 (fr) * | 1987-02-02 | 1988-08-11 | Pfizer Inc. | Sel de sodium en cristaux anhydres de 5-chloro-3-(2-thenoyle)-2-oxindole-1-carboxamide |
| GB8720693D0 (en) * | 1987-09-03 | 1987-10-07 | Glaxo Group Ltd | Chemical compounds |
| US4853409A (en) * | 1988-04-13 | 1989-08-01 | Pfizer Inc. | 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function |
| US4861794A (en) * | 1988-04-13 | 1989-08-29 | Pfizer Inc. | 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis |
| US5182289A (en) * | 1988-06-14 | 1993-01-26 | Schering Corporation | Heterobicyclic compounds having antiinflammatory activity |
| AU3776589A (en) * | 1988-06-14 | 1990-01-12 | Schering Corporation | Heterobicyclic compounds having antiinflammatory activity |
| WO1990008145A1 (fr) * | 1989-01-10 | 1990-07-26 | Pfizer Inc. | 1-heteroaryl-3-acyl-2-indoxyles anti-inflammatoires |
| US5300655A (en) * | 1989-04-18 | 1994-04-05 | Pfizer Inc. | 2-carboxy-thiophene derivatives |
| US5047554A (en) * | 1989-04-18 | 1991-09-10 | Pfizer Inc. | 3-substituted-2-oxindole derivatives |
| US4952703A (en) * | 1989-05-25 | 1990-08-28 | Pfizer Inc. | Intermediates for making 2-oxindole-1-carboxamides |
| US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
| US5179119A (en) * | 1989-08-02 | 1993-01-12 | Hoechst-Roussel Pharmaceuticals Incorporated | 1,3-dihydro-1-(pyridinylamino)-2H-indol-1-ones and intermediates for the preparation thereof |
| IL95880A (en) * | 1989-10-13 | 1995-12-31 | Pfizer | Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis |
| WO1991009598A1 (fr) * | 1990-01-05 | 1991-07-11 | Pfizer Inc. | Derives de l'azaoxindole |
| US5064851A (en) * | 1990-07-24 | 1991-11-12 | Pfizer Inc. | 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use |
| US5298522A (en) * | 1993-01-22 | 1994-03-29 | Pfizer Inc. | 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio |
| DK0683777T3 (da) * | 1993-02-09 | 1997-04-28 | Pfizer | Oxindol-1-N-(alkoxycarbonyl)carboxamider og -1-(N-carboxamido)carboxamider som antiinflammatoriske midler |
| DE69430877T2 (de) * | 1993-04-09 | 2003-02-06 | Sony Corp., Tokio/Tokyo | Bildkodierungsverfahren und -vorrichtung |
| US5359068A (en) * | 1993-06-28 | 1994-10-25 | Pfizer Inc. | Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one |
| US5502072A (en) * | 1993-11-26 | 1996-03-26 | Pfizer Inc. | Substituted oxindoles |
| US5449788A (en) * | 1994-01-28 | 1995-09-12 | Catalytica, Inc. | Process for preparing 2-oxindole-1-carboxamides |
| US6469181B1 (en) | 1995-01-30 | 2002-10-22 | Catalytica, Inc. | Process for preparing 2-oxindoles and N-hydroxy-2-oxindoles |
| JP2004529110A (ja) | 2001-03-06 | 2004-09-24 | アストラゼネカ アクチボラグ | 脈管損傷活性を有するインドール誘導体 |
| WO2003009815A2 (fr) | 2001-07-25 | 2003-02-06 | Biomarin Pharmaceutical Inc. | Compositions et procedes de modulation du transport a travers la barriere hematho-encephalique |
| AU2002349675A1 (en) * | 2001-12-05 | 2003-06-17 | Shionogi And Co., Ltd. | Derivative having hiv integrase inhibitory activity |
| BR0309412A (pt) * | 2002-04-22 | 2005-02-01 | Pfizer Prod Inc | Indol-2-onas como inibidores seletivos da ciclooxigenase-2 |
| AR053710A1 (es) | 2005-04-11 | 2007-05-16 | Xenon Pharmaceuticals Inc | Compuestos espiroheterociclicos y sus usos como agentes terapeuticos |
| MY158766A (en) | 2005-04-11 | 2016-11-15 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
| AR056317A1 (es) * | 2005-04-20 | 2007-10-03 | Xenon Pharmaceuticals Inc | Compuestos de oxindol y composicion farmaceutica |
| SI1889198T1 (sl) | 2005-04-28 | 2015-02-27 | Proteus Digital Health, Inc. | Farma-informacijski sistem |
| EP2063905B1 (fr) | 2006-09-18 | 2014-07-30 | Raptor Pharmaceutical Inc | Traitement des troubles hépatiques par l'administration de conjugués de protéine associée au récepteur (rap) |
| CN103271906A (zh) | 2006-10-12 | 2013-09-04 | 泽农医药公司 | 螺-吲哚酮化合物作为治疗剂的用途 |
| JP5554337B2 (ja) | 2008-10-17 | 2014-07-23 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | 治療剤としてのスピロオキシインドール化合物およびそれらの使用 |
| WO2010045197A1 (fr) | 2008-10-17 | 2010-04-22 | Xenon Pharmaceuticals, Inc. | Composés spiro-oxindole et leur utilisation comme agents thérapeutiques |
| DK2398500T3 (da) | 2009-02-20 | 2019-05-13 | 2 Bbb Medicines B V | Glutathion-baseret lægemiddelafgivelsessystem |
| SG175896A1 (en) | 2009-05-06 | 2011-12-29 | Lab Skin Care Inc | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
| RU2015103694A (ru) | 2009-10-14 | 2015-06-27 | Ксенон Фармасьютикалз Инк. | Способы синтеза спиро-оксиндольных соединений |
| RU2016128400A (ru) | 2010-02-26 | 2018-12-06 | Ксенон Фармасьютикалз Инк. | Фармацевтические композиции спиро-оксиндольного соединения для местного введения и их применение в качестве терапевтических агентов |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
| TW201636017A (zh) | 2015-02-05 | 2016-10-16 | 梯瓦製藥國際有限責任公司 | 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法 |
| WO2016179157A1 (fr) | 2015-05-05 | 2016-11-10 | Carafe Drug Innovation, Llc | 5-hydroxyoxindoles substitués et leur utilisation en tant qu'analgésiques et réducteurs de fièvre |
| MA56056A (fr) * | 2019-11-01 | 2022-04-06 | Fmc Agro Singapore Pte Ltd | Nouveau procédé efficace de synthèse de 2-amino-5-chloro-n-,3-diméthylbenzamide |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL125443C (fr) * | 1963-06-06 | |||
| GB1089071A (en) * | 1964-02-28 | 1967-11-01 | Merck & Co Inc | Indole derivatives |
| US3462450A (en) * | 1966-06-29 | 1969-08-19 | Merck & Co Inc | Chemical compounds |
| GB1158532A (en) * | 1967-01-05 | 1969-07-16 | Centre Nat Rech Scient | 2-Oxoindoline-3-Carboxylic Acids and Esters thereof |
| US3631177A (en) * | 1967-04-18 | 1971-12-28 | Smith Kline French Lab | 3-phenacyl-2-oxoindolines |
| US3519592A (en) * | 1967-04-18 | 1970-07-07 | Smithkline Corp | Indole compounds |
| BE714717A (fr) * | 1967-05-12 | 1968-09-30 | ||
| FR7337M (fr) * | 1968-01-11 | 1969-10-13 | ||
| BE756447A (fr) * | 1969-10-15 | 1971-03-22 | Pfizer | Oxindolecarboxamides |
| US3749731A (en) * | 1971-07-08 | 1973-07-31 | Warner Lambert Co | 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide |
| US4012394A (en) * | 1973-02-16 | 1977-03-15 | Labaz | Indole derivatives |
| US3975531A (en) * | 1973-10-02 | 1976-08-17 | A. H. Robins Company, Incorporated | 4-(5- And 7-)benzoylindolin-2-ones and pharmaceutical uses thereof |
| US4221716A (en) * | 1979-02-16 | 1980-09-09 | A. H. Robins Company, Inc. | Intermediate and process for the preparation of 7-acylindolin-2-ones |
-
1985
- 1985-03-22 US US06/714,012 patent/US4569942A/en not_active Expired - Lifetime
- 1985-04-30 DE DE8585303044T patent/DE3571320D1/de not_active Expired
- 1985-04-30 AT AT87200969T patent/ATE53576T1/de not_active IP Right Cessation
- 1985-04-30 DE DE8787200969T patent/DE3578173D1/de not_active Expired - Lifetime
- 1985-04-30 AT AT85303044T patent/ATE44380T1/de not_active IP Right Cessation
- 1985-04-30 EP EP87200969A patent/EP0244918B1/fr not_active Expired - Lifetime
- 1985-04-30 EP EP85303044A patent/EP0164860B1/fr not_active Expired
- 1985-05-01 NZ NZ211938A patent/NZ211938A/xx unknown
- 1985-05-02 DK DK197685A patent/DK162644C/da not_active IP Right Cessation
- 1985-05-02 CA CA000480573A patent/CA1255658A/fr not_active Expired
- 1985-05-02 IL IL75077A patent/IL75077A/xx not_active IP Right Cessation
- 1985-05-02 GR GR851061A patent/GR851061B/el unknown
- 1985-05-03 PH PH32231A patent/PH22981A/en unknown
- 1985-05-03 AU AU41938/85A patent/AU554290B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NZ211938A (en) | 1988-08-30 |
| DK197685A (da) | 1985-11-05 |
| DK162644B (da) | 1991-11-25 |
| DK197685D0 (da) | 1985-05-02 |
| EP0164860B1 (fr) | 1989-07-05 |
| CA1255658A (fr) | 1989-06-13 |
| ATE44380T1 (de) | 1989-07-15 |
| AU554290B2 (en) | 1986-08-14 |
| EP0244918A3 (en) | 1989-02-22 |
| ATE53576T1 (de) | 1990-06-15 |
| DK162644C (da) | 1992-04-13 |
| IL75077A0 (en) | 1985-09-29 |
| EP0244918A2 (fr) | 1987-11-11 |
| EP0164860A1 (fr) | 1985-12-18 |
| AU4193885A (en) | 1985-11-07 |
| DE3571320D1 (en) | 1989-08-10 |
| US4569942A (en) | 1986-02-11 |
| DE3578173D1 (de) | 1990-07-19 |
| EP0244918B1 (fr) | 1990-06-13 |
| GR851061B (fr) | 1985-11-25 |
| PH22981A (en) | 1989-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL75077A (en) | N,3-disubstituted 2-oxindole-1-carboxamides and pharmaceutical compositions containing them | |
| AU3632684A (en) | Oxygen containing heterocyclic derivatives of 2,2-imino-bisethanol | |
| IE791099L (en) | Histamine h2 antagonists | |
| ES8609272A1 (es) | Un procedimiento para preparar derivados de hidantoina | |
| PH21257A (en) | 11-substituted 5-h,11-pyrrolo,(2,1-c)benzoxazepine and their use as medicaments | |
| ES8609271A1 (es) | Procedimiento para preparar derivados de carbamoilimidazol fungicidas | |
| DE3568776D1 (en) | 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents | |
| ES8601153A1 (es) | Procedimiento para la obtencion de derivados de acido barbi-turico | |
| EG17752A (en) | Benzoylurea derivatives | |
| PH22656A (en) | Heterocyclic compounds and pharmaceutical composition containing thereof | |
| DE3660959D1 (de) | Benz-trisubstituted 2-aminotetralins | |
| GB8627301D0 (en) | Heterocyclic compounds | |
| DE3672635D1 (de) | Esterderivate von 2,2-dimethyl-3-ethenylcyclopropancarbonsaeure, ihre herstellung, ihre verwendung als parasitizide und sie enthaltende zusammensetzungen. | |
| ES2061406A1 (es) | Nuevos derivados de la 2-(quinolina) con actividad farmacologica. | |
| ATE16280T1 (de) | Salze von mikrobiziden naphthyridin- bzw. chinolinverbindungen und ihre herstellung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |